Abstract
We examined the associations between the polymorphic alleles of the DNA repair genes XRCC1 (c.839G>A, rs25489; and c.1196A>G, rs25487), XPA (c.-4A>G, rs1800975), and XPD (c.2251A>C, rs13181) and the progression and severity of neoplasias in the urinary bladder and kidney in patients of three distinct ethnic groups, Bashkir, Russians, and Tatar, residing in the Republic of Bashkorostan. The study enrolled 468 cancer patients and 351 healthy individuals. Genoty** for polymorphic alleles was carried out using the PCR-RFLP method. We identified an association between allele A of the c.839G>A locus of the XRCC1 gene and the incidence of the bladder cancer (BC) and renal cell carcinoma (RCC) in the Tatar study group, using the additive genetic effects model (Odds Ratio (OR) = 5.23 and OR = 3.90). In turn, the heterozygous G/A genotype frequency was significantly higher in the RCC patients of Bashkir ethnic origin, compared with the control group (p = 0.0061, OR = 4.72). Additional analysis with consideration of participants smoking status showed that the G/A genotype is significantly more frequent in smokers with BC (OR = 1.96, p = 0.05) than in healthy smokers. We also determined, using the recessive genetic model, that the genotype A/A of the c.1196A>G locus of the XRCC1 gene was associated with a higher risk of BC in the Russian cohort (OR = 2.29, p = 0.0082) and an increased incidence of RCC in the Bashkir group (OR = 4.06, p = 0.05). A similar association was obtained for smokers. In contrast, the allele c.2251A>C in the XPD gene associated with a lower risk for BC and RCC in the Tatars (p = 0.0003, OR = 0.48 and p < 0.0001, OR = 0.37) in the additive model and in the Bashkirs (p = 0.0083, OR = 0.12) and Russians (p = 0.0001, OR = 0.14) in the recessive model. Further, we uncovered that polymorphism c.839G>A in the XRCC1 gene contributes to the progression of noninvasive and invasive BC and promotes RCC at early and advanced stages of the disease. Thus, we identified similar associations between DNA repair gene polymorphisms and the incidence and progression of BC and RCC. We propose that this result points to the involvement of common pathogenetic mechanisms in the initiation and progression of the urinary neoplasias.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
GLOBOCAN 2002. http://www.dep.iarc.fr/globocan/globocan.htm
European Association of Urology: Guidelines, 2013.
Glantz, S.A., Primer of Biostatistics New York: McGraw-Hill, 1997, 4th ed.
Rodriguez, S., Gaunt, T.R., and Day, I.N.M., Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies, Am. J. Epidemiol. Adv., 2009. doi 10.1093/aje/kwn359
Kochetova, O.V., Korytina, G.F., Akhmadishina, L.Z., and Victorova, T.V., Polymorphisms of DNA repair genes (XRCC1, XRCC3, XPC, XPD, XPA) in ethnic groups from republic of Bashkortostan, Russ. J. Genet., 2013, vol. 49, no. 8, pp. 870–876.
Rakitin, S.S., Dmitrieva, A.I., Novitskii, V.V., et al., Genetic polymorphism of the DNA reparation system among gastric cancer patients with different histological tumor types, Fundam. Issled., 2011, no. 3, pp. 125–130.
Ladige, W.C., Mouse models of XRCC1 DNA repair polymorphisms and cancer, Oncogene, 2006, no. 25, pp. 1612–1619.
Mao, Y., Xu, X., Lin, Y., et al., Quantitative assessment of the associations between XRCC1 polymorphisms and BC risk, World J. Surg. Oncol., 2013, vol. 11, no. 58. http://www.wjso.com/content/11/1/58
Zhang, K., Zhou, B., Wang, Y., et al., The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: an update by meta-analysis of 53 individual studies, Gene, 2012, no. 510, pp. 93–101.
Zhuo, W., Zhang, L., Cai, L., et al., XRCC1 Arg280His polymorphism and BC risk: updated meta-analyses based on 5767 cases and 6919 controls, Exp. Biol. Med., 2013, vol. 238, no. 1, pp. 66–76.
Hirata, H., Hinoda, Y., Matsuyama, H., et al., Polymorphisms of DNA repair genes are associated with renal cell carcinoma, Biochem. Biophys. Res. Commun., 2006, vol. 342, no. 4, pp. 1058–1062.
Sakano, S., Hinoda, Y., Okayama, N., et al., The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma, Ann. Oncol., 2007, vol. 18, no. 11, pp. 1817–1827.
Benhamoul, S. and Sarasin, A., ERCC2/XPD gene polymorphisms and lung cancer: a huge review, Am. J. Epidemiol., 2005, no. 161, pp. 1–14.
Tiseo, M., Bordi, P., Bortesi, B., et al., ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin, Br. J. Cancer, 2013. doi: 10.1038/bjc.2013.127
Wang, M., Gu, D., Zhang, Z., et al., XPD polymorphisms, cigarette smoking, and BC risk: a meta-analysis, J. Toxicol. Environ. Health A, 2009, vol. 72, nos. 11–12, pp. 698–705.
Sobti, R.C., Kaur, S., Sharma, V.L., et al., Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population, DNA Cell Boil., 2012, vol. 31, no. 2, pp. 199–210.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.Z. Akhmadishina, I.R. Gilyazova, L.R. Kutlyeva, G.F. Korytina, O.V. Kochetova, M.F. Urmantsev, S.M. Izmailova, A.A. Izmailov, G.B. Kunsbaeva, A.A. Zagidullin, A.A. Khaliullin, V.N. Pavlov, T.V. Victorova, E.K. Khusnutdinova, 2014, published in Genetika, 2014, Vol. 50, No. 4, pp. 481–490.
Rights and permissions
About this article
Cite this article
Akhmadishina, L.Z., Gilyazova, I.R., Kutlyeva, L.R. et al. DNA repair XPCC1 and XPD genes polymorphism as associated with the development of bladder cancer and renal cell carcinoma. Russ J Genet 50, 421–429 (2014). https://doi.org/10.1134/S1022795414040024
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795414040024